(Total Views: 52)
Posted On: 01/09/2024 10:21:13 AM
Post# of 43997

$XRTX Alliance Global Partners analyst James Molloy maintains XORTX Therapeutics (NASDAQ: XRTX) with a Buy and raises the price target from $9 to $14.
https://www.alsahm.com/news/content/alliance-...2024-01-04
https://www.alsahm.com/news/content/alliance-...2024-01-04

